Literature DB >> 14729977

ASPP1 and ASPP2: common activators of p53 family members.

Daniele Bergamaschi1, Yardena Samuels, Boquan Jin, Sai Duraisingham, Tim Crook, Xin Lu.   

Abstract

We recently showed that ASPP1 and ASPP2 stimulate the apoptotic function of p53. We show here that ASPP1 and ASPP2 also induce apoptosis independently of p53. By binding to p63 and p73 in vitro and in vivo, ASPP1 and ASPP2 stimulate the transactivation function of p63 and p73 on the promoters of Bax, PIG3, and PUMA but not mdm2 or p21(WAF-1/CIP1). The expression of ASPP1 and ASPP2 also enhances the apoptotic function of p63 and p73 by selectively inducing the expression of endogenous p53 target genes, such as PIG3 and PUMA, but not mdm2 or p21(WAF-1/CIP1). Removal of endogenous p63 or p73 with RNA interference demonstrated that (16) the p53-independent apoptotic function of ASPP1 and ASPP2 is mediated mainly by p63 and p73. Hence, ASPP1 and ASPP2 are the first two identified common activators of all p53 family members. All these results suggest that ASPP1 and ASPP2 could suppress tumor growth even in tumors expressing mutant p53.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14729977      PMCID: PMC321425          DOI: 10.1128/MCB.24.3.1341-1350.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  24 in total

Review 1.  Live or let die: the cell's response to p53.

Authors:  Karen H Vousden; Xin Lu
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

2.  p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.

Authors:  A Yang; M Kaghad; Y Wang; E Gillett; M D Fleming; V Dötsch; N C Andrews; D Caput; F McKeon
Journal:  Mol Cell       Date:  1998-09       Impact factor: 17.970

3.  Viral oncoproteins discriminate between p53 and the p53 homolog p73.

Authors:  M C Marin; C A Jost; M S Irwin; J A DeCaprio; D Caput; W G Kaelin
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

4.  Recruitment of p300/CBP in p53-dependent signal pathways.

Authors:  M L Avantaggiati; V Ogryzko; K Gardner; A Giordano; A S Levine; K Kelly
Journal:  Cell       Date:  1997-06-27       Impact factor: 41.582

5.  p73 is a simian [correction of human] p53-related protein that can induce apoptosis.

Authors:  C A Jost; M C Marin; W G Kaelin
Journal:  Nature       Date:  1997-09-11       Impact factor: 49.962

6.  Regulation of p53 stability by Mdm2.

Authors:  M H Kubbutat; S N Jones; K H Vousden
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

7.  Mdm2 promotes the rapid degradation of p53.

Authors:  Y Haupt; R Maya; A Kazaz; M Oren
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

8.  Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers.

Authors:  M Kaghad; H Bonnet; A Yang; L Creancier; J C Biscan; A Valent; A Minty; P Chalon; J M Lelias; X Dumont; P Ferrara; F McKeon; D Caput
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

9.  Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression.

Authors:  Hidetaka Uramoto; Hiroto Izumi; Gunji Nagatani; Haruki Ohmori; Naofumi Nagasue; Tomoko Ise; Takeshi Yoshida; Kosei Yasumoto; Kimitoshi Kohno
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

10.  The large T antigen of simian virus 40 binds and inactivates p53 but not p73.

Authors:  M Dobbelstein; J Roth
Journal:  J Gen Virol       Date:  1998-12       Impact factor: 3.891

View more
  85 in total

1.  CCR5 blockade is well tolerated and induces changes in the tissue distribution of CCR5+ and CD25+ T cells in healthy, SIV-uninfected rhesus macaques.

Authors:  Jessica E Taaffe; Steven E Bosinger; Gregory Q Del Prete; James G Else; Sarah Ratcliffe; Christopher D Ward; Thi Migone; Mirko Paiardini; Guido Silvestri
Journal:  J Med Primatol       Date:  2011-11-14       Impact factor: 0.667

2.  Apoptosis and disease: a life or death decision.

Authors:  Marion MacFarlane; Ann C Williams
Journal:  EMBO Rep       Date:  2004-06-25       Impact factor: 8.807

3.  An indirect role for ASPP1 in limiting p53-dependent p21 expression and cellular senescence.

Authors:  Arnaud M Vigneron; Karen H Vousden
Journal:  EMBO J       Date:  2011-11-08       Impact factor: 11.598

Review 4.  Tied up in loops: positive and negative autoregulation of p53.

Authors:  Xin Lu
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-09       Impact factor: 10.005

5.  p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2.

Authors:  Marshall Urist; Tomoaki Tanaka; Masha V Poyurovsky; Carol Prives
Journal:  Genes Dev       Date:  2004-12-15       Impact factor: 11.361

6.  Crystal structure of SV40 large T-antigen bound to p53: interplay between a viral oncoprotein and a cellular tumor suppressor.

Authors:  Wayne Lilyestrom; Michael G Klein; Rongguang Zhang; Andrzej Joachimiak; Xiaojiang S Chen
Journal:  Genes Dev       Date:  2006-09-01       Impact factor: 11.361

7.  Mechanisms of regulatory diversity within the p53 transcriptional network.

Authors:  J M Espinosa
Journal:  Oncogene       Date:  2008-02-18       Impact factor: 9.867

Review 8.  The p53 family and programmed cell death.

Authors:  E C Pietsch; S M Sykes; S B McMahon; M E Murphy
Journal:  Oncogene       Date:  2008-10-27       Impact factor: 9.867

Review 9.  Another fork in the road--life or death decisions by the tumour suppressor p53.

Authors:  Luis A Carvajal; James J Manfredi
Journal:  EMBO Rep       Date:  2013-04-16       Impact factor: 8.807

10.  N terminus of ASPP2 binds to Ras and enhances Ras/Raf/MEK/ERK activation to promote oncogene-induced senescence.

Authors:  Zhiping Wang; Yuangang Liu; Maho Takahashi; Kathryn Van Hook; Kerstin M Kampa-Schittenhelm; Brett C Sheppard; Rosalie C Sears; Philip J S Stork; Charles D Lopez
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.